Secondary skin involvement by systemic de novo CD5-positive diffuse large B-cell lymphoma.
Secondary skin involvement by systemic de novo CD5-positive diffuse large B-cell lymphoma.
复制标题
全身性新发 CD5 阳性弥漫性大 B 细胞淋巴瘤继发性皮肤受累。
DOI:
10.1111/1346-8138.14082
复制
发表时间:
2018
期刊:
影响因子:
--
通讯作者:
Kanekura T.
中科院分区:
文献类型:
--
作者:
Baba N;Fujii K;Ibusuki A;Higashi Y;Kawai K;Kanekura T.
Dear Editor, An 88-year-old woman presented with a 1-month history of a cutaneous tumor on her right cheek (Fig. 1a) with nasal obstruction. She had no history of lymphoproliferative disorders and did not have B symptoms. Physical examination revealed a 25 mm 9 12 mm, dark red colored plaques at the nasojugal fold without tenderness. Skin biopsy showed diffuse infiltration of large atypical lymphoid cells throughout the dermis and at the bottom marginal edge of the specimen (Fig. 1b, c). Immunohistochemically, the tumor cells expressed CD20, CD79a, BCL2 and BCL6. They were also positive for CD5 (Fig. 1d–h). CD10, CD56, MUM1 and cyclin D1 were negative, as was Epstein–Barr virus-encoded sRNA in situ hybridization. Many small lymphocytes were also seen and these cells were CD3 positive (Fig. 1i), and histiocytes were also observed. Southern blot analysis failed to detect monoclonal rearrangement of the IgH gene. Karyotype analysis of the biopsy specimen revealed the deletion of chromosomes 11 and 14 and two marker chromosomes (46, XX,-11,-14,+ 2 mar). Peripheral blood analysis did not identify significant anomalies; serum chemistry including lactate dehydrogenase was within normal limits. Serum soluble interleukin-2 receptor was 6792 U/mL (range,